An Overview of Thrombin Inhibitors in the Perspective of Structure-activity Relationships

被引：3
|
作者：
Wang, Jiangming [1 ]
Sun, Xiaojing [1 ]
Li, Na [1 ]
Sheng, Ruilong [2 ]
Guo, Ruihua [1 ,3 ,4 ]
机构：
[1] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai 201306, Peoples R China
[2] Univ Madeira, CQM Cent Quim Madeira, Campus Penteada, P-9000390 Funchal, Portugal
[3] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai 201306, Peoples R China
[4] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stora, Shanghai 201306, Peoples R China
来源：
CURRENT MEDICINAL CHEMISTRY | 2023年 / 30卷 / 25期
基金：
中国国家自然科学基金;
关键词：
Antithrombotic; thrombin inhibitor; structure-activity relationship; pharmacokinetics; PROTEASE-ACTIVATED RECEPTORS; DESIGNING ALLOSTERIC REGULATORS; OPTIMIZING PLATELET INHIBITION; ORALLY BIOAVAILABLE SERIES; FACTOR XA INHIBITORS; BIOLOGICAL EVALUATION; ANTITHROMBOTIC COMPOUNDS; IN-VITRO; PART; SCUTELLAREIN DERIVATIVES;
D O I：
10.2174/0929867329666220906105200
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thrombosis is one of the most important pathogenic factors related to cardiovascular diseases. Presently, thrombin inhibitors have gradually gained prominence in clinical practice due to their unique potential, such as dabigatran. Nevertheless, the risk of bleeding is not completely eliminated, and the threats of gastrointestinal bleeding are even increased in some cases. Therefore, developing new oral thrombin inhibitors with low side effects is urgent. In this paper, we summarized recent advances in the newly synthesized and isolated thrombin inhibitors from 2000 to 2019 and their structure-activity relationships (SARs) along with structure-dependent pharmacokinetic parameters, guiding the next generation of oral thrombin inhibitors.
引用
收藏
页码：2864 / 2930
页数：67
相关论文
共 50 条
  • [21] Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)
    Pick, Anne
    Mueller, Henrik
    Mayer, Ralf
    Haenisch, Britta
    Pajeva, Ilza K.
    Weigt, Mathias
    Boenisch, Heinz
    Mueller, Christa E.
    Wiese, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (06) : 2090 - 2102
  • [22] Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose
    Zhang, Bo-wei
    Xing, Yan
    Wen, Chen
    Yu, Xiao-xia
    Sun, Wen-long
    Xiu, Zhi-long
    Dong, Yue-sheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (22) : 5065 - 5070
  • [23] Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX)
    East, James E.
    Kennedy, Andrew J.
    Tomsig, Jose L.
    De Leon, Alexandra R.
    Lynch, Kevin R.
    Macdonald, Timothy L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 7132 - 7136
  • [24] Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors
    Lv, Peng-Cheng
    Sun, Juan
    Luo, Yin
    Yang, Ying
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4657 - 4660
  • [25] Structure-activity relationships of Toxoplasma gondii cytochrome bc1 inhibitors
    Alday, P. Holland
    Nilsen, Aaron
    Doggett, J. Stone
    EXPERT OPINION ON DRUG DISCOVERY, 2022, 17 (09) : 997 - 1011
  • [26] An Update of Synthetic Approaches and Structure-Activity Relationships of Various Classes of Human MAO-B Inhibitors
    Sharma, Pratibha
    Singh, Manjinder
    Mathew, Bijo
    CHEMISTRYSELECT, 2021, 6 (07): : 1404 - 1429
  • [27] The nematocidal activity and the structure-activity relationships of stilbenes
    Kohno, Tukasa
    Togashi, Katsumi
    Fukamiya, Narihiko
    NATURAL PRODUCT RESEARCH, 2007, 21 (07) : 606 - 615
  • [28] Structure-activity relationships of steroids with mineralocorticoid activity
    Grassy, G
    Fagart, J
    Calas, B
    Adenot, M
    Rafestin-Oblin, ME
    Auzou, G
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (11) : 869 - 879
  • [29] Honokiol and magnolol: A review of structure-activity relationships of their derivatives
    Dai, Si-Yang
    Qin, Wen-Xiu
    Yu, Shuo
    Li, Chang
    Yang, Yi-Hui
    Pei, Yue-Hu
    PHYTOCHEMISTRY, 2024, 223
  • [30] Non-thiol farnesyltransferase inhibitors: Structure-activity relationships of aralkylsubsituted benzophenones
    Mitsch, A
    Wissner, P
    Sattler, I
    Schlitzer, M
    ARCHIV DER PHARMAZIE, 2001, 334 (02) : 40 - 44
12345